We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

AUTOBIO DIAGNOSTICS CO., LTD

Autobio Diagnostics Co., Ltd is a clinical diagnostics company specializing in research & development, production, ma... read more Featured Products: More products

Download Mobile App





Autobio Diagnostics Showcases Automated Microbial Identification and ID-AST Solutions at ECCMID 2022

By LabMedica International staff writers
Posted on 25 Apr 2022
Print article
Image: AutoMic-i600 (Photo courtesy of Autobio Diagnostics)
Image: AutoMic-i600 (Photo courtesy of Autobio Diagnostics)

Autobio Diagnostics Co., Ltd. (Zhengzhou, Henan, China) showcased its fully automated microbial identification and antibiotic susceptibility testing (ID-AST) solutions at this year’s ECCMID, the largest international meeting of clinical microbiologists and infectious diseases specialists.

At ECCMID 2022, Autobio demonstrated the AutoMic-I600 automated ID-AST system for quick and accurate microbial identification and ID-AST that supports automatic sample pipetting, incubation and detection. Five different antibiotic cards, including the most comprehensive antibiotic panels, help microbiologists to find out suitable antimicrobial treatment within much shorter time cost. It supports random placement of multiple varieties of board card along with bidirectional intelligent identification and matching of board card and specimen. With two determination methods (colorimetric and turbidimetric), and four wavelength detection, continuous automated interpretation, and AI algorithm model, the AutoMic-I600 ensures scientific and accurate results.

In addition, Autobio highlighted its MALDI-TOF MS (Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry) system for use in microbiological clinical laboratories for the identification of pathogenic bacteria, especially microaerobes, anaerobes, mycobacteria and fungi. Its powerful database includes more than 16,000 strains covering more than 5,000 species and 1000 genera along with a unique filamentous fungi database of more than 1,000 strains covering 450 +species and 70+ genera. Autobio’s MALDI-TOF MS system features a localized and updatable microbial strain database for high identification accuracy. Autobio also presented the AutoMimo system to improve pipetting efficiency and optimize workflow in the lab when conducting experiments with its MALDI TOF microbial identification system. The instrument is also compatible with MALDI TOF of other brands.

Related Links:
Autobio Diagnostics Co., Ltd. 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.